List view / Grid view
14 July 2015 | By Victoria White
The first patient has been recruited into a Phase IIa clinical trial to test the efficacy, safety and tolerability profile of Lorediplon in insomnia...
14 July 2015 | By Victoria White
The FDA has approved Iressa for the first-line treatment of patients with NSCLC whose tumours have EGFR exon 19 deletions or exon 21 substitution mutations...
13 July 2015 | By Victoria White
pSivida has announced positive top-line results from a Phase II investigator-sponsored study of Medidur for uveitis affecting the posterior of the eye...
13 July 2015 | By Victoria White
Anacor has announced positive preliminary top-line results from its two Phase 3 pivotal studies of crisaborole in atopic dermatitis (eczema)...
Yusen Logistics (Mexico) S.A. DE C.V. opened two offices inside and outside at the Mexico City Airport on June 1. By establishing a base on the airport front lines to manage its own air transportation operations, the company aims to realize competitive freight procurement and detailed transportation management of imported…
13 July 2015 | By Victoria White
NICE has recommended anti-blood clotting drug Lixiana as an option for treating and preventing the recurrence of potentially fatal blood clots...
13 July 2015 | By Victoria White
Novo Nordisk has released headline results from SUSTAIN1, the first Phase 3a trial for semaglutide, a GLP-1 analogue administered once-weekly...
13 July 2015 | By Victoria White
In the Phase II IMvigor 210 study, Roche’s atezolizumab shrank tumours in people with locally advanced or metastatic urothelial bladder cancer (UBC)...
13 July 2015 | By Victoria White
The SMC has announced that sorafenib has been accepted for use within NHS Scotland for the treatment of patients with thyroid carcinoma...
10 July 2015 | By Victoria White
Janssen-Cilag International announced today that the European Commission (EC) has approved Imbruvica® (ibrutinib) capsules as a treatment option for adult patients with Waldenström’s macroglobulinemia (WM).
10 July 2015 | By Victoria White
Edoxaban, a new blood-thinning drug therapy to help prevent stroke in patients with non-valvular atrial fibrillation, has been launched in the UK...
10 July 2015 | By Victoria White
Lilly has issued a statement in response to the US Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee’s ongoing review of necitumumab...
10 July 2015 | By Victoria White
Vedolizumab, a drug to treat Crohn’s disease, has been recommended for routine NHS funding by the UK's National Institute for Health and Care Excellence...
10 July 2015 | By Victoria White
Fresenius Kabi and Calea have been sentenced for supplying hospitals with defective pre-filled syringes that contributed to the death of a diabetic patient...
9 July 2015 | By Victoria White
Market Access Consultants Curo have received the highest accolade given to British businesses, the Queen’s Award for Enterprise...
